The Trump Administration issued a notice on Monday titled, “Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients,” which could serve...more
4/17/2025
/ Imports ,
International Emergency Economic Powers Act (IEEPA) ,
International Trade ,
National Security ,
Pharmaceutical Industry ,
Public Comment ,
Regulatory Requirements ,
Section 232 ,
Supply Chain ,
Tariffs ,
Trump Administration
On Wednesday, April 2, 2025, President Donald Trump held a press conference to describe and sign an Executive Order (EO) establishing sweeping “reciprocal tariffs” on nearly all imports to the US, as outlined below....more
Just after midnight on March 4, 2025, President Donald Trump began to implement new tariffs on goods imported from Mexico, Canada, and China – the three largest trading partners of the US, accounting for over 40 percent of US...more
3/7/2025
/ Canada ,
China ,
Duties ,
Executive Orders ,
Imports ,
Mexico ,
Retaliation ,
Supply Chain ,
Tariffs ,
Trade Wars ,
Trump Administration ,
United States-Mexico-Canada Agreement (USMCA) ,
US Trade Policies
Multinational manufacturers are encouraged to consider how to adapt their supply chains to a complex landscape. While US tariffs on Canada and Mexico were postponed by a month, a ten-percent universal tariff on all Chinese...more
2/18/2025
/ Canada ,
China ,
EU ,
Imports ,
International Trade ,
Mexico ,
Supply Chain ,
Tariffs ,
Trade Relations ,
Trump Administration ,
UK ,
US Trade Policies
On February 13, 2025, President Donald Trump issued a Presidential Memorandum directing a rapid review process to determine country-specific “reciprocal tariffs” for all US trading partners based on each partner’s perceived...more
2/17/2025
/ Foreign Policy ,
Foreign Trade Regulations ,
Infrastructure ,
Retaliatory Tariffs ,
Section 301 ,
Supply Chain ,
Tariffs ,
Trade Relations ,
Trump Administration ,
U.S. Commerce Department ,
U.S. Treasury ,
USTR